Baqsimi 3 MG spray two packs
Ended Awarded
- Contract number
- SPE2DB26FCQQD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,732
Award facts
- Contract value 100% obligated
- $13,731.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for BAQSIMI 3 mg spray two-packs valued at $13,731.90 on October 16, 2025. This competitive, firm fixed-price delivery order was issued without a set-aside designation and is scheduled for completion by October 17, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies a broad range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. BAQSIMI is an emergency glucagon auto-injector used for severe hypoglycemia treatment, representing the type of specialized medical commodity the contractor regularly delivers through the DLA Medical Supply Chain. The prime IDC vehicle supports the company's ability to fulfill diverse pharmaceutical needs across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard, demonstrating AmerisourceBergen's role as a key provider within federal defense healthcare procurement.
Quick answers
Who was awarded contract SPE2DB26FCQQD?
SPE2DB26FCQQD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 16, 2025.
How much is contract SPE2DB26FCQQD worth?
The government has obligated $13,732 on SPE2DB26FCQQD.
Is contract SPE2DB26FCQQD an order under another contract?
Yes. SPE2DB26FCQQD is a delivery order under SPE2DB24D1205, an indefinite delivery contract.
Was contract SPE2DB26FCQQD competed?
The extent of competition for SPE2DB26FCQQD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award